Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses
- 1 August 1978
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 81 (2) , 171-177
- https://doi.org/10.1017/s0022172400024992
Abstract
Summary: Replication of vaccinia and monkeypox viruses was impeded in the presence of 5-bromodeoxyuridine (BUdR) in RL-33 cells derived from rabbit lung tissue. The different degree of inhibition was found among strains of those viruses, in which it was evident that five strains (CV-1, Lister, IHD, Dairen-I and Ikeda) of vaccinia viruses resulted in more reduced yields of infectious virus than four strains (Sen-19, Orang Utan, Copenhagen and Sierra Leone) of monkeypox viruses. There was also strain variation in BUdR sensitivity within vaccinia viruses but not in the case of monkeypox viruses.This publication has 12 references indexed in Scilit:
- ESTABLISHMENT OF A RABBIT LUNG CELL LINE (RL-33) AND ITS VIRAL SUSCEPTIBILITYJapanese Journal of Medical Science and Biology, 1977
- Three Specific Antigens Produced in Vaccinia, Variola, and Monkeypox InfectionsThe Journal of Infectious Diseases, 1974
- Human infection with monkeypox virus: laboratory investigation of six cases in West Africa.1972
- An unusual poxvirus from Nigeria.1972
- Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man.1972
- Histopathological and virological studies on monkeypoxArchiv für die gesamte Virusforschung, 1967
- Conditional lethal mutants of rabbitpox virusVirology, 1966
- The effect of light on poliovirus grown in neutral redVirology, 1965
- The effect of 5-bromodeoxyuridine on the multiplication of vaccinia virusVirology, 1963
- A POX‐LIKE DISEASE IN CYNOMOLGUS MONKEYSActa Pathologica Microbiologica Scandinavica, 1959